<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biores Open Access</journal-id>
<journal-id journal-id-type="iso-abbrev">Biores Open Access</journal-id>
<journal-id journal-id-type="publisher-id">biores</journal-id>
<journal-title-group>
<journal-title>BioResearch Open Access</journal-title>
</journal-title-group>
<issn pub-type="ppub">2164-7844</issn>
<issn pub-type="epub">2164-7860</issn>
<publisher>
<publisher-name>Mary Ann Liebert, Inc.</publisher-name>
<publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30069423</article-id>
<article-id pub-id-type="pmc">6069589</article-id>
<article-id pub-id-type="publisher-id">10.1089/biores.2018.0017</article-id>
<article-id pub-id-type="doi">10.1089/biores.2018.0017</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A New Approach to Treating Neurodegenerative Otologic Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Moos</surname>
<given-names>Walter H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1,</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2,</sup>
</xref>
<xref ref-type="corresp" rid="corr1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Faller</surname>
<given-names>Douglas V.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3,</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glavas</surname>
<given-names>Ioannis P.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harpp</surname>
<given-names>David N.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6,</sup>
</xref>
<xref ref-type="corresp" rid="corr1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Irwin</surname>
<given-names>Michael H.</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanara</surname>
<given-names>Iphigenia</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinkert</surname>
<given-names>Carl A.</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Powers</surname>
<given-names>Whitney R.</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>10,</sup>
</xref>
<xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steliou</surname>
<given-names>Kosta</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4,</sup>
</xref>
<xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vavvas</surname>
<given-names>Demetrios G.</given-names>
</name>
<xref ref-type="aff" rid="aff13">
<sup>13,</sup>
</xref>
<xref ref-type="aff" rid="aff14">
<sup>14</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kodukula</surname>
<given-names>Krishna</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2,</sup>
</xref>
<xref ref-type="aff" rid="aff12">
<sup>12,</sup>
</xref>
<xref ref-type="aff" rid="aff15">
<sup>15,</sup>
</xref>
<xref ref-type="corresp" rid="corr1">
<sup>*</sup>
</xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>Department of Pharmaceutical Chemistry, School of Pharmacy, <institution>University of California San Francisco</institution>, San Francisco, California.</aff>
<aff id="aff2"><label><sup>2</sup></label><institution>ShangPharma Innovation, Inc.</institution>, South San Francisco, California.</aff>
<aff id="aff3"><label><sup>3</sup></label>Department of Medicine, <institution>Boston University School of Medicine</institution>, Boston, Massachusetts.</aff>
<aff id="aff4"><label><sup>4</sup></label>Cancer Research Center, <institution>Boston University School of Medicine</institution>, Boston, Massachusetts.</aff>
<aff id="aff5"><label><sup>5</sup></label>Department of Ophthalmology, <institution>New York University School of Medicine</institution>, New York, New York.</aff>
<aff id="aff6"><label><sup>6</sup></label>Department of Chemistry, Office for Science &amp; Society, <institution>McGill University</institution>, Montreal, <country>Canada</country>.</aff>
<aff id="aff7"><label><sup>7</sup></label>Department of Pathobiology, College of Veterinary Medicine, <institution>Auburn University</institution>, Auburn, Alabama.</aff>
<aff id="aff8"><label><sup>8</sup></label><institution>Embassy of Greece in Moscow</institution>, Moscow, <country>Russia</country>.</aff>
<aff id="aff9"><label><sup>9</sup></label>Department of Biological Sciences, College of Arts and Sciences, <institution>The University of Alabama</institution>, Tuscaloosa, Alabama.</aff>
<aff id="aff10"><label><sup>10</sup></label>Department of Health Sciences, <institution>Boston University</institution>, Boston, Massachusetts.</aff>
<aff id="aff11"><label><sup>11</sup></label>Department of Anatomy, <institution>Boston University School of Medicine</institution>, Boston, Massachusetts.</aff>
<aff id="aff12"><label><sup>12</sup></label><institution>PhenoMatriX, Inc.</institution>, Natick, Massachusetts.</aff>
<aff id="aff13"><label><sup>13</sup></label>Retina Service, Angiogenesis Laboratory, <institution>Massachusetts Eye and Ear Infirmary</institution>, Boston, Massachusetts.</aff>
<aff id="aff14"><label><sup>14</sup></label>Department of Ophthalmology, <institution>Harvard Medical School</institution>, Boston, Massachusetts.</aff>
<aff id="aff15"><label><sup>15</sup></label><institution>Bridgewater College</institution>, Bridgewater, Virginia.</aff>
</contrib-group>
<author-notes>
<fn id="fn1">
<p>Dedicated to the late Richard H. Tomlinson, Canadian philanthropist and champion of functional hearing aids for the public.</p>
</fn>
<corresp id="corr1"><label><sup>*</sup></label>Address correspondence to: Walter H. Moos, PhD, Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, UCSF Box 2280, 600 16th Street, Genentech Hall S512D, San Francisco, CA 94143, <email>walter.moos@ucsf.edu</email> or David N. Harpp, PhD, Department of Chemistry, Office for Science &amp; Society, McGill University, 801 Sherbrooke Street West, Montreal H3A 0B8, QC, Canada, <email>david.n.harpp@mcgill.ca</email> or Krishna Kodukula, PhD, ShangPharma Innovation, Inc., 280 Utah Avenue, South San Francisco, CA 94080, <email>kkodukula@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>7</month>
<year>2018</year>
<!--string-date: July 2018-->
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2018</year>
<!--string-date: July 2018-->
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>7</volume>
<issue>1</issue>
<fpage>107</fpage>
<lpage>115</lpage>
<permissions>
<copyright-statement>© Walter H. Moos <italic>et al</italic>. 2018; Published by Mary Ann Liebert, Inc.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>This Open Access article is distributed under the terms of the Creative Commons License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="biores.2018.0017.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p>Hearing loss, the most common neurological disorder and the fourth leading cause of years lived with disability, can have profound effects on quality of life. The impact of this “invisible disability,” with significant consequences, economic and personal, is most substantial in low- and middle-income countries, where &gt;80% of affected people live. Given the importance of hearing for communication, enjoyment, and safety, with up to 500 million affected globally at a cost of nearly $800 billion/year, research on new approaches toward prevention and treatment is attracting increased attention. The consequences of noise pollution are largely preventable, but irreversible hearing loss can result from aging, disease, or drug side effects. Once damage occurs, treatment relies on hearing aids and cochlear implants. Preventing, delaying, or reducing some degree of hearing loss may be possible by avoiding excessive noise and addressing major contributory factors such as cardiovascular risk. However, given the magnitude of the problem, these interventions alone are unlikely to be sufficient. Recent advances in understanding principal mechanisms that govern hearing function, together with new drug discovery paradigms designed to identify efficacious therapies, bode well for pharmaceutical intervention. This review surveys various causes of loss of auditory function and discusses potential neurological underpinnings, including mitochondrial dysfunction. Mitochondria mitigate cell protection, survival, and function and may succumb to cumulative degradation of energy production and performance; the end result is cell death. Energy-demanding neurons and vestibulocochlear hair cells are vulnerable to mitochondrial dysfunction, and hearing impairment and deafness are characteristic of neurodegenerative mitochondrial disease phenotypes. Beyond acting as cellular powerhouses, mitochondria regulate immune responses to infections, and studies of this phenomenon have aided in identifying nuclear factor kappa B and nuclear factor erythroid 2-related factor 2/antioxidant response element signaling as targets for discovery of otologic drugs, respectively, suppressing or upregulating these pathways. Treatment with free radical scavenging antioxidants is one therapeutic approach, with lipoic acid and corresponding carnitine esters exhibiting improved biodistribution and other features showing promise. These compounds are also histone deacetylase (HDAC) inhibitors, adding epigenetic modulation to the mechanistic milieu through which they act. These data suggest that new drugs targeting mitochondrial dysfunction and modulating epigenetic pathways via HDAC inhibition or other mechanisms hold great promise.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title><bold>Keywords:</bold> </title>
<kwd>carnitine esters</kwd>
<kwd>epigenetics</kwd>
<kwd>hearing loss</kwd>
<kwd>lipoic acid</kwd>
<kwd>mitochondrial dysfunction</kwd>
<kwd>pharmaceutical</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="2"></table-count>
<ref-count count="141"></ref-count>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s001">
<title>Background</title>
<p>Vision is the pre-eminent sensory means by which we navigate the world around us,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> while the ability to hear endows us with the power of voice communication. It enriches our lives with the sound of music and alerts us to imminent danger that can be heard although perhaps not seen. The Greek physician-philosopher Alcmaeon of Croton<sup><xref ref-type="bibr" rid="B2">2–5</xref></sup> and his two protagonist followers, Praxagoras of Kos<sup><xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref></sup> and the great Alexandrian physician of Chalcedon,<sup><xref ref-type="bibr" rid="B7">7</xref></sup> Herophilus,<sup><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref></sup> propounded that hearing is a construct of the brain, where external sound channeled to it through the ears (transduced into sensorineural signals) is interpreted.<sup><xref ref-type="bibr" rid="B6">6</xref></sup></p>
<p>Hearing loss is the most common neurological disorder affecting people worldwide.<sup><xref ref-type="bibr" rid="B8">8</xref></sup> The World Health Organization (WHO) estimates that the annual cost of unaddressed hearing loss is in the range of $750–790 billion globally.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> In the “Global Burden of Disease,” impaired hearing represents the fourth leading cause of disability worldwide.<sup><xref ref-type="bibr" rid="B10">10–12</xref></sup> About 5–7% of the world's population (∼360–500 million people) has a hearing disability<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup> that is severe enough in more than 80% of people older than 85 years to interfere with their ability to communicate effectively.<sup><xref ref-type="bibr" rid="B10">10</xref></sup> In children, impaired hearing can impinge on their academic potential and social development<sup><xref ref-type="bibr" rid="B13">13</xref></sup> with lifelong adverse consequences.<sup><xref ref-type="bibr" rid="B14">14</xref></sup> Hearing loss due to mechanical (conductive) and/or anatomical issues in the outer and/or middle ear (<xref ref-type="fig" rid="f1">Fig. 1</xref>) is less prevalent than that resulting from dysfunction in the cochlea and/or the auditory nerves (sensorineural) in the inner ear or a mixture of conductive and sensorineural components.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B15">15</xref></sup></p>
<fig fig-type="figure" id="f1" orientation="portrait" position="float">
<label>
<bold>FIG. 1.</bold>
</label>
<caption>
<p>Anatomy of the human ear. <bold>(a)</bold> The outer ear includes the ear lobe and auditory canal; middle ear, the tympanic membrane and cavity; the inner ear, the hearing (cochlea) and balance (vestibular system) organs and the attached associated nerves connecting to the brain. (Figure reproduced from Chittka L, Brockmann A. Perception space—the final frontier. PLoS Biol. 2005;3(4):e137. CC BY 2.5 (<uri xlink:href="http://creativecommons.org/licenses/by/2.5/deed.en" xlink:type="simple">https://creativecommons.org/licenses/by/2.5/deed.en</uri>), via Wikimedia Commons. Original File URL: <uri xlink:href="http://commons.wikimedia.org/wiki/File:Anatomy_of_the_Human_Ear_en.svg" xlink:type="simple">https://commons.wikimedia.org/wiki/File:Anatomy_of_the_Human_Ear_en.svg</uri>) <bold>(b)</bold> Expanded cross section of the cochlea (organ of Corti) showing the outer and inner hair cells, and the spiral ganglion of the cochlear nerve. (Cochlea-crosssection.png. CC BY-SA 3.0 US (<uri xlink:href="http://creativecommons.org/licenses/by-sa/3.0/us/" xlink:type="simple">https://creativecommons.org/licenses/by-sa/3.0/us/</uri>), via Wikimedia Commons. Original File URL: <uri xlink:href="http://commons.wikimedia.org/wiki/File:Organ_of_corti.svg" xlink:type="simple">https://commons.wikimedia.org/wiki/File:Organ_of_corti.svg</uri>)</p>
</caption>
<graphic xlink:href="fig-1"></graphic>
</fig>
<p>Although the array of techniques used in the diagnosis of sensorineural hearing loss (SNHL, the predominant form of hearing loss worldwide) is progressively being expanded and refined,<sup><xref ref-type="bibr" rid="B14">14</xref></sup> developing therapeutics to treat the onset of SNHL is proving to be considerably more difficult to realize<sup><xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref></sup>—thus placing a premium emphasis on prevention.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B16">16</xref></sup> A compelling case for prevention is noise-induced hearing loss (NIHL), one of the most common types of SNHL.<sup><xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref></sup> Noise pollution is a growing health problem around the world.<sup><xref ref-type="bibr" rid="B19">19–22</xref></sup> For example, in the United States alone, it is estimated that more than 25% of the adult population has measurable hearing loss caused by exposure to harmful noise.<sup><xref ref-type="bibr" rid="B10">10</xref></sup> Irreversible hearing loss can also be the product of disease<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref></sup> and is often an unfortunate side effect of the aminoglycoside antibiotics<sup><xref ref-type="bibr" rid="B25">25–30</xref></sup> and platin-based anticancer drugs.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B30">30–36</xref></sup> Regrettably, once damage has occurred, hearing aids and cochlear implantation are the only compensatory options presently available for affected individuals.<sup><xref ref-type="bibr" rid="B37">37</xref></sup></p>
<p>There is a substantial and growing worldwide unmet medical need for a pharmaceutical approach to treating hearing impairment.<sup><xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref></sup> SNHL results from damage to the organ of Corti (<xref ref-type="fig" rid="f1">Fig. 1</xref>), causing the degeneration of spiral ganglion neurons due to excessive injury and/or untoward death of cochlear hair cells in the inner ear,<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref></sup> in most cases caused by internal or external pathologic factors, including infectious or inflammatory processes, ototoxic drugs, noise overstimulation, as well as the normal aging process.<sup><xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B42">42</xref></sup> Unexpectedly, a recent meta-analysis of numerous epidemiological studies exposed a possible link between presbycusis (also known as age-related hearing loss, ARHL) and cognitive decline, cognitive impairment, and dementia—suggesting that ARHL may be a relevant biomarker and a targetable modifiable risk factor for dementia.<sup><xref ref-type="bibr" rid="B43">43–46</xref></sup> However, given that advanced age itself is a leading risk factor for dementia,<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B47">47–49</xref></sup> the meta-analysis correlation is not surprising.</p>
</sec>
<sec id="s002">
<title>Mitochondrial Dysfunction in Hearing Loss</title>
<p>Mitochondria mitigate cell protection, survival, and function<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B50">50–52</xref></sup> (Hoffman ME, Augsburger BN, Foradori CD, et al. Neuroprotective effects of carnitinoid compounds in rodent cellular and in vivo models of mitochondrial complex I dysfunction. 2018; submitted) and, over time, they succumb to an increasing cumulative degradation of their cellular energy production and performance—driving the cell toward death (apoptosis) and/or premature senescence (Hoffman et al., submitted).<sup><xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B53">53–59</xref></sup> Energy-demanding cells such as neurons and the vestibulocochlear hair cells (<xref ref-type="fig" rid="f1">Fig. 1</xref>) are especially vulnerable to mitochondrial dysfunction<sup><xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref></sup> and, consequently, hearing impairment/deafness is a characteristic clinical symptom of several neurodegenerative mitochondrial disease phenotypes.<sup><xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B62">62–66</xref></sup></p>
<p>Focusing on the genetic basis of hearing loss, it is worth noting that many mutations in the mitochondrial genome (mitochondrial DNA, mtDNA), as well as in the nuclear genome (nuclear DNA, nDNA), are known to cause hearing deficits (<xref ref-type="table" rid="T1">Table 1</xref>).<sup><xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B65">65–67</xref></sup> Alterations in certain regions of mtDNA associated with deafness are also associated with a host of other disorders, such as myopathy including cardiomyopathy, diabetes, and parkinsonism.<sup><xref ref-type="bibr" rid="B68">68–72</xref></sup></p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>
<bold>Representative Mitochondrial Disorders Associated with Hearing Impairment/Deafness</bold>
</p>
</caption>
<!--OASIS TABLE HERE-->
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Disease</th>
<th align="center">Abbreviation</th>
<th align="center">mtDNA/RNA<sup><xref ref-type="table-fn" rid="tf1">a</xref></sup></th>
<th align="center">Defect, presence of symptom, sign or finding, and other notes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Aminoglycoside-induced deafness</td>
<td align="left">AID</td>
<td align="left">Mutation in rRNA</td>
<td align="left">Also associated with Parkinson's disease</td>
</tr>
<tr>
<td align="left">Kearns-Sayre syndrome</td>
<td align="left">KSS</td>
<td align="left">Large-scale deletions</td>
<td align="left">Possible presence of sensorineural hearing loss</td>
</tr>
<tr>
<td align="left">Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes</td>
<td align="left">MELAS</td>
<td align="left">Mutation in tRNA</td>
<td align="left"> </td>
</tr>
<tr>
<td align="left">Maternally inherited deafness and diabetes</td>
<td align="left">MIDD</td>
<td align="left">Mutation in RNA</td>
<td align="left">Phenotypically and genotypically heterogeneous</td>
</tr>
<tr>
<td align="left">Mohr-Tranebjaerg syndrome</td>
<td align="left">MTS</td>
<td align="left">Mutations in nDNA</td>
<td align="left">Causes defects in mitochondrial protein import machinery</td>
</tr>
<tr>
<td align="left">Myoclonic epilepsy with ragged red fibers</td>
<td align="left">MERFF</td>
<td align="left">Mutation in tRNA</td>
<td align="left"> </td>
</tr>
<tr>
<td align="left">Neuropathy, ataxia, and retinitis pigmentosa</td>
<td align="left">NARP</td>
<td align="left">Mutation in mRNA</td>
<td align="left">Possible presence of sensorineural hearing loss</td>
</tr>
<tr>
<td align="left">Progressive external ophthalmoplegia</td>
<td align="left">PEO</td>
<td align="left">Multiple deletions</td>
<td align="left">Ophthalmoplegia is a clinical hallmark of multiple deletions in mtDNA</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tf1">
<label>
<sup>a</sup>
</label>
<p>Unless otherwise noted.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In addition, mitochondria are key regulators of our innate and adaptive immune responses to viral infections.<sup><xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B73">73–76</xref></sup> Often overlooked among the many causes of impaired hearing, including deafness, is virus-induced hearing loss.<sup><xref ref-type="bibr" rid="B77">77–79</xref></sup> Although the mechanisms of hearing loss/deafness associated with viral infections remain largely undefined,<sup><xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B80">80</xref></sup> viral infections activate a cascade of mitochondrial antiviral innate immune responses that include nuclear factor kappa B (NF-κB)<sup><xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B80">80</xref>,<xref ref-type="bibr" rid="B81">81</xref></sup> and nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathways.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B76">76</xref></sup></p>
<p>Unmitigated oxidative stress (which is primarily caused by mitochondrial dysfunction) and epigenetically altered expression of genes sensing oxidative stress are significant contributors to the pathogenicity of neurodegenerative disorders (Hoffman et al., submitted).<sup><xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B83">83</xref></sup> While a full understanding of these pathways awaits further study, it seems clear that epigenetics plays a significant role. Mammalian vestibulocochlear hair cells are a stress-sensitive, nonregenerative cell type and, like the retinal cells of the eye,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> are not replaced when they are injured or die.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B84">84–86</xref></sup> Interestingly, emerging research indicates we selectively amplify directional sound in a noisy environment by unconsciously utilizing eye–ear coordination to integrate visual cues with the auditory information.<sup><xref ref-type="bibr" rid="B87">87</xref>,<xref ref-type="bibr" rid="B88">88</xref></sup> Assessing vision and oculomotor function is essential in the diagnostic evaluation of vestibulocochlear auditory impairments,<sup><xref ref-type="bibr" rid="B89">89</xref></sup> particularly in patients with idiopathic etiology.<sup><xref ref-type="bibr" rid="B90">90</xref>,<xref ref-type="bibr" rid="B91">91</xref></sup></p>
</sec>
<sec id="s003">
<title>α-Lipoic Acid, <sc>l</sc>-Carnitine, and Butyrate</title>
<p>Impressive advances in gene therapy<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B92">92–94</xref></sup> and regenerative medicine are making inroads toward regenerating hair cells with the aim of reversing hearing loss.<sup><xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B95">95</xref></sup> Some of the achievements demonstrate therapeutic potential,<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B86">86</xref></sup> but a clinical application is still a long way off.<sup><xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B39">39</xref></sup> In the more immediate future, shielding hair cells from oxidative damage and/or rescuing injured hair cells from falling into apoptosis by pharmacological treatment with free radical scavenging antioxidant compounds portend a promising therapeutic approach.<sup><xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B96">96–99</xref></sup></p>
<p>Upregulating <italic>Nrf2/ARE</italic> gene expression pathways and/or suppressing NF-κB signaling are cogent targets for pharmaceutical intervention strategies.<sup><xref ref-type="bibr" rid="B34">34</xref></sup> Many natural and synthetic compounds are known inhibitors of NF-κB signaling<sup><xref ref-type="bibr" rid="B100">100</xref></sup>—butyric acid (butyrate)<sup><xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B101">101–105</xref></sup> and α-lipoic acid (5-[(3<italic>R</italic>)-1,2-dithiolan-3-yl]pentanoic acid)<sup><xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B106">106–110</xref></sup> (<xref ref-type="fig" rid="f2">Fig. 2</xref>) are among them. Importantly, butyric acid and α-lipoic acid (ALA), as well as their respective corresponding <sc>l</sc>-carnitine esters PMX550DBr and PMX500FI (<xref ref-type="fig" rid="f2">Fig. 2</xref>), also act as antioxidant histone deacetylase (HDAC) inhibitors (HDACi) (Hoffman et al., submitted).<sup><xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B54">54</xref></sup> noted for effecting favorable epigenetic modulation of the cell survival protein, B cell lymphoma 2 (Bcl-2) with respect to the proapoptotic protein, Bcl-2-associated X protein (BAX) in a BAX/Bcl-2 ratio of 1:2.<sup><xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B110">110–113</xref></sup> Again, note the implied potential of drugs that modulate epigenetic pathways.</p>
<fig fig-type="figure" id="f2" orientation="portrait" position="float">
<label>
<bold>FIG. 2.</bold>
</label>
<caption>
<p>Chemical structures of butyric acid, ALA, and their corresponding carnitine esters. ALA, α-lipoic acid.</p>
</caption>
<graphic xlink:href="fig-2"></graphic>
</fig>
<p>ALA has been extensively researched as a neuroprotectant,<sup><xref ref-type="bibr" rid="B114">114–119</xref></sup> acting on signaling mechanisms through both receptor-mediated pathways and nonreceptor-mediated antioxidant processes in a variety of cell types<sup><xref ref-type="bibr" rid="B110">110</xref>,<xref ref-type="bibr" rid="B115">115</xref>,<xref ref-type="bibr" rid="B116">116</xref>,<xref ref-type="bibr" rid="B119">119</xref>,<xref ref-type="bibr" rid="B120">120</xref></sup>—including cochlear hair cells.<sup><xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B122">122</xref></sup> In humans, ALA is a functionally versatile endogenous molecule enzymatically synthesized in mitochondria from octanoic acid.<sup><xref ref-type="bibr" rid="B123">123</xref></sup> It is a key cofactor in the construction of vital metabolic multienzyme complexes, including pyruvate dehydrogenase and the glycine cleavage system.<sup><xref ref-type="bibr" rid="B123">123</xref></sup> It is also a strong antioxidant<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B119">119</xref>,<xref ref-type="bibr" rid="B124">124</xref>,<xref ref-type="bibr" rid="B125">125</xref></sup> and anti-inflammatory<sup><xref ref-type="bibr" rid="B109">109</xref>,<xref ref-type="bibr" rid="B119">119</xref>,<xref ref-type="bibr" rid="B125">125</xref></sup> agent capable of activating and modulating signal transduction pathways,<sup><xref ref-type="bibr" rid="B109">109</xref>,<xref ref-type="bibr" rid="B119">119</xref>,<xref ref-type="bibr" rid="B126">126</xref></sup> upregulating the expression of nerve growth factor, and augmenting the conduction velocity of motor nerves.<sup><xref ref-type="bibr" rid="B127">127</xref></sup></p>
<p>The expression of ∼1% (∼200–250 genes) of the protein-coding human genome is modulated in concert with the Nrf2/ARE signaling pathway.<sup><xref ref-type="bibr" rid="B117">117</xref>,<xref ref-type="bibr" rid="B128">128</xref></sup> ALA is a potent activator of Nrf2, a transcription factor encoded by <italic>NFE2L2</italic> that helps regulate cellular redox balance and protective antioxidant and phase II detoxification responses in mammals.<sup><xref ref-type="bibr" rid="B50">50</xref></sup> Dietary antioxidant supplements are commonly sought by patients and caregivers for treating primary mitochondrial disorders.<sup><xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B65">65</xref></sup> The role of antioxidants in prevention of age-related hearing loss has been reviewed by Tavanai and Mohammadkhani.<sup><xref ref-type="bibr" rid="B129">129</xref></sup> In one of the reviewed studies, C57BL/6 mice fed with control diet or diet containing 1 of 17 antioxidant compounds (acetyl-<sc>l</sc>-carnitine, <italic>N</italic>-acetyl-<sc>l</sc>-cysteine (NAC), ALA, carotene, carnosine, coenzyme Q<sub>10</sub>, curcumin, tocopherol, epigallocatechin-3-gallate, gallic acid, lutein, lycopene, melatonin, proanthocyanidin, quercetin, resveratrol, or tannic acid), ARHL was nearly completely prevented by ALA and coenzyme Q<sub>10</sub> and partially by NAC, but not by the other compounds.<sup><xref ref-type="bibr" rid="B130">130</xref></sup> Unfortunately, this strategy showed no significant benefit in an interventional human study.<sup><xref ref-type="bibr" rid="B131">131</xref></sup></p>
<p>However, the results from the Polanski and Cruz<sup><xref ref-type="bibr" rid="B131">131</xref></sup> study may not truly address the ability of antioxidants to prevent ARHL because the design of the study was not directed toward prevention, and damaged cochlear hair cells are not restored by antioxidants.<sup><xref ref-type="bibr" rid="B129">129</xref></sup> In studies aimed at preventing hearing loss in aged animals, ALA was shown to confer significant hearing preservation.<sup><xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B108">108</xref></sup> Similar results between human and animal studies<sup><xref ref-type="bibr" rid="B99">99</xref></sup> were also observed with the use of <sc>l</sc>-carnitine—an endogenously synthesized molecule mostly obtained from the diet.<sup><xref ref-type="bibr" rid="B65">65</xref></sup></p>
<p>NF-κB is a transcription factor that regulates the expression of a variety of genes involved in inflammation and immunity.<sup><xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B104">104</xref>,<xref ref-type="bibr" rid="B105">105</xref></sup> Sodium butyrate is a well-documented HDAC inhibitor<sup><xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B105">105</xref></sup> that has demonstrated anti-inflammatory NF-κB inhibition properties.<sup><xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B101">101–105</xref></sup> Butyrate mediates NF-κB activation by rescuing the redox machinery and controlling reactive oxygen species<sup><xref ref-type="bibr" rid="B105">105</xref></sup> that are highly injurious to hair cells<sup><xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B132">132</xref></sup> by suppressing the NF-κB signaling pathways.<sup><xref ref-type="bibr" rid="B105">105</xref></sup></p>
<p>Although ALA and butyrate are common food and diet supplements that can be safely taken in high doses, their bioavailability is not prolonged or sustained at an effective therapeutic level.<sup><xref ref-type="bibr" rid="B50">50</xref></sup> Furthermore, a recent Phase I clinical trial in age-related macular degeneration evaluating the safety and tolerability of ALA in 15 subjects, 65 years of age or older, showed that high doses (800–1200 mg) of racemic ALA cannot be tolerated very well by patients.<sup><xref ref-type="bibr" rid="B133">133</xref></sup> Thus, in the treatment of hearing loss, a need for ALA and butyrate derivatives having more clinically suitable pharmacokinetics is a challenging pharmaceutical objective.</p>
</sec>
<sec id="s004">
<title>Concluding Remarks</title>
<p>Hearing impairment is a major global health concern; its massive impact seemingly unrecognized until recently, and the affected population largely untreated. Preventing, or at least delaying or reducing, some hearing loss may be possible by avoiding excessive noise exposure and addressing contributory factors such as cardiovascular risk, infectious diseases, neurological disorders, and drug toxicity. However, these interventions will not be sufficient given the sheer magnitude of the problem. Thus, in view of recent advances in our understanding of the underlying mechanistic pathways—both mitochondrial and epigenetic—that govern hearing function, coupled with new drug discovery paradigms that can today be exploited to identify new and effective therapies, the time is ripe to tackle hearing loss with novel medicines. Alcmaeon of Croton remarked that vision and hearing are constructs of the brain. We see and hear in our dreams and in some aspects of disease conditions, such as high fever, schizophrenia, psychosis, or the later stages of dementia, and our dreams may blend into our conscious state immersed in auditory and/or visual hallucinations and delusions. The most common hallucination in schizophrenia is hearing voices.<sup><xref ref-type="bibr" rid="B134">134</xref>,<xref ref-type="bibr" rid="B135">135</xref></sup> Finally, readers are directed to <xref ref-type="table" rid="T2">Table 2</xref> for a summary of key points related to otologic disorders.</p>
<table-wrap id="T2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>
<bold>Selected Key Points</bold>
</p>
</caption>
<!--OASIS TABLE HERE-->
<table frame="hsides" rules="groups">
<col align="left"/>
<tbody>
<tr>
<td align="left">• Roughly 1 in 15 people worldwide—about 500 million—suffer from disabling hearing loss; two to three times that number have mild-to-complete hearing loss.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup></td>
</tr>
<tr>
<td align="left">• Recent studies proclaim hearing problems as the fourth leading cause of YLDs; clearly a major global health concern.<sup><xref ref-type="bibr" rid="B10 B11 B12">10–12</xref></sup></td>
</tr>
<tr>
<td align="left">• Hearing impairment has been called an “invisible disability” despite its significant consequences, economic and personal; the impact is most substantial in LMICs, where &gt;80% of people with hearing loss reside.<sup><xref ref-type="bibr" rid="B44">44</xref></sup></td>
</tr>
<tr>
<td align="left">• Noise exposure is a major cause of deafness and hearing impairment (i.e., noise-induced hearing loss); cardiovascular risk caused by diabetes and smoking is also associated with hearing loss.<sup><xref ref-type="bibr" rid="B22">22</xref></sup></td>
</tr>
<tr>
<td align="left">• Hearing impairment in children and adults may also present as sequelae of cytomegalovirus, Ebola virus, and other serious infections.<sup><xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B121">121</xref></sup></td>
</tr>
<tr>
<td align="left">• Advanced age is a major risk factor for hearing loss (i.e., presbycusis, age-related hearing loss), with U.S. prevalence nearly 70% over age 70; indeed, age-related hearing loss may prove to be a useful biomarker and treatable risk factor for cognitive decline or impairment, including Alzheimer's disease.<sup><xref ref-type="bibr" rid="B43 B44 B45 B46">43–46</xref></sup></td>
</tr>
<tr>
<td align="left">• Hearing loss has been observed following TBI, and while it is significant clinically it is yet to be well characterized.<sup><xref ref-type="bibr" rid="B92">92</xref>,<xref ref-type="bibr" rid="B136">136</xref></sup></td>
</tr>
<tr>
<td align="left">• Genetics, both mitochondrial and nuclear, and demographics (educational level, race/ethnicity, sex) have an influence on, or are associated with, hearing disorders.<sup><xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B72">72</xref>,<xref ref-type="bibr" rid="B82">82</xref></sup></td>
</tr>
<tr>
<td align="left">• The most common congenital sensory impairment is hearing loss, affecting between 1 in 300 to 500 newborns and children to the age of 4; one example results from disruption of a gene that encodes a major component of cochlear gap junctions.<sup><xref ref-type="bibr" rid="B137">137</xref></sup></td>
</tr>
<tr>
<td align="left">• It is not uncommon to see links between sensorineural deficits in both the ear and the eye; RP, an inherited eye disease, is in some cases associated with reduced hearing ability.<sup><xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B89">89</xref></sup></td>
</tr>
<tr>
<td align="left">• Sensorineural hearing loss is found in mitochondrial respiratory chain disorders, and mtDNA mutations represent one of the most important causes of hearing loss <xref ref-type="table" rid="T1">Table 1</xref><sup><xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref></sup>; given the high energy demands of hearing, mitochondrial involvement should not be a surprise.<sup><xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref></sup></td>
</tr>
<tr>
<td align="left">• Certain drugs (<xref ref-type="fig" rid="f3">Fig. 3</xref>), notably aminoglycoside antibiotics (gentamicin), antivirals (ganciclovir), antifungals (amphotericin B), antimalarials (chloroquine), antituberculosis agents (capreomycin), cardiovascular drugs (furosemide), anticonvulsants (valproic acid), cisplatin (platinol), and immunosuppressants (tacrolimus), can result in significant hearing loss.<sup><xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B28">28</xref></sup> Ototoxicity is a potential side effect of some commonly used NSAID and related medications, including acetaminophen (paracetamol) and ibuprofen when taken in very high doses or used chronically (≥2 days/week).<sup><xref ref-type="bibr" rid="B42">42</xref></sup> In lieu of a recent study suggesting that, if started early enough, a daily regimen of ibuprofen can prevent the onset of Alzheimer's disease,<sup><xref ref-type="bibr" rid="B138">138</xref></sup> ototoxicity in this protocol is an important consideration to take into account.</td>
</tr>
<tr>
<td align="left">• From a pharmaceutical perspective, the chemical structural diversity (<xref ref-type="fig" rid="f3">Fig. 3</xref>) of potentially ototoxic drugs is noteworthy.</td>
</tr>
<tr>
<td align="left">• Drug discovery to identify novel therapeutics that protect hair cells from toxic insults is experimentally challenging owing to the inaccessibility of the inner ear, but zebrafish and other animal models have been explored; screens have identified multiple potential drug classes of interest, for example, antioxidants,<sup><xref ref-type="bibr" rid="B122">122</xref></sup> and other compounds acting on classical GPCR neurotransmitter systems (i.e., adrenergic, dopaminergic, serotoninergic) and estrogen receptor modulators.<sup><xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B99">99</xref></sup></td>
</tr>
<tr>
<td align="left">• Biotechnology and pharmaceutical companies have recognized the unmet medical need and therapeutic potential of new drugs for hearing impairment, as exemplified by ventures such as Aurin, Auris, Autifony, Decibel, Frequency, Novus, Otonomy, Sensorion, and Sound, among others<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B97">97</xref></sup>; still relatively untapped in this respect are epigenetic and mitochondrial targets.<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>,<xref ref-type="bibr" rid="B132">132</xref>,<xref ref-type="bibr" rid="B139 B140 B141">139–141</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tf2">
<p>GPCR, G-protein-coupled receptor; LMICs, low- and middle-income countries; NSAID, nonsteroidal anti-inflammatory drug; RP, retinitis pigmentosa; TBI, traumatic brain injury; YLDs, years lived with disability.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig fig-type="figure" id="f3" orientation="portrait" position="float">
<label>
<bold>FIG. 3.</bold>
</label>
<caption>
<p>Wide ranging chemical structures of potentially ototoxic drugs.</p>
</caption>
<graphic xlink:href="fig-3"></graphic>
</fig>
</sec>
</body>
<back>
<sec id="s005" sec-type="ack">
<title>Acknowledgments</title>
<p>We gratefully acknowledge the generous financial support from the MitoCure Foundation and thank Dr. Robert J. Zamboni (Zamboni Chem Solutions, McGill University) for his invaluable advice and helpful discussions in the preparation of this article.</p>
</sec>
<sec id="s006">
<title>Authors' Contributions</title>
<p>All authors contributed to the writing of this article and agreed to its final content.</p>
</sec>
<sec id="s007" sec-type="COI-statement">
<title>Author Disclosure Statement</title>
<p>K.S. owns shares in PhenoMatriX, Inc. K.K. and W.H.M. consult with and/or serve on the boards of various biotechnology and pharmaceutical companies from time to time, where they may receive compensation including stock options, and they receive compensation from ShangPharma Innovation, Inc., a healthcare venture capital firm. For all other authors, no competing financial interests exist.</p>
</sec>
<ref-list content-type="parsed">
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moos</surname><given-names>WH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faller</surname><given-names>DV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Glavas</surname><given-names>IP</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epigenetic treatment of neurodegenerative ophthalmic disorders: an eye toward the future</article-title>. <source/>BioRes Open Access. <year>2017</year>;<volume>6</volume>:<fpage>169</fpage>–<lpage>181</lpage><pub-id pub-id-type="pmid">29291141</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Bowder</surname><given-names>D</given-names></name></person-group> (ed.) <source/>Who was who in the Greek world: 776 BC–30 BC. <publisher-name>Cornell University Press</publisher-name>: <publisher-loc>Ithaca, NY</publisher-loc>, <year>1982</year></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sebastian</surname><given-names>A</given-names></name></person-group>
<source/>A Dictionary of the History of Medicine. <publisher-name>Routledge</publisher-name>: <publisher-loc>London</publisher-loc>, p. <fpage>788</fpage>; <year>1999</year> eBook Available at: <uri xlink:href="http://www.taylorfrancis.com/books/9781351470001" xlink:type="simple">www.taylorfrancis.com/books/9781351470001</uri> Accessed February 6, 2018</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debernardi</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sala</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>D'Aliberti</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Alcmaeon of Croton</article-title>. <source/>Neurosurgery. <year>2010</year>;<volume>66</volume>:<fpage>247</fpage>–<lpage>252</lpage><pub-id pub-id-type="pmid">20087125</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zemelka</surname><given-names>AM</given-names></name></person-group>
<article-title>Alcmaeon of Croton—father of neuroscience? Brain, mind and senses in the Alcmaeon's study</article-title>. <source/>J Neurol Neurosci. <year>2017</year>;<volume>8</volume>:<fpage>3</fpage></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panegyres</surname><given-names>KP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Panegyres</surname><given-names>PK</given-names></name></person-group>
<article-title>The ancient Greek discovery of the nervous system: Alcmaeon, Praxagoras and Herophilus</article-title>. <source/>J Clin Neurosci. <year>2016</year>;<volume>29</volume>:<fpage>21</fpage>–<lpage>24</lpage><pub-id pub-id-type="pmid">26898584</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Standring</surname><given-names>S</given-names></name></person-group>
<article-title>A brief history of topographical anatomy</article-title>. <source/>J Anat. <year>2016</year>;<volume>229</volume>:<fpage>32</fpage>–<lpage>62</lpage><pub-id pub-id-type="pmid">27278889</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shubina-Oleinik</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Holt</surname><given-names>JR</given-names></name></person-group>
<article-title>Emerging gene therapies for genetic hearing loss</article-title>. <source/>JARO. <year>2017</year>;<volume>18</volume>:<fpage>649</fpage>–<lpage>670</lpage><pub-id pub-id-type="pmid">28815315</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="web"><collab>WHO Report</collab>. <article-title>Global costs of unaddressed hearing loss and cost-effectiveness of interventions</article-title>. <year>2017</year> Available at: <uri xlink:href="http://apps.who.int/iris/bitstream/10665/254659/1/9789241512046-eng.pdf" xlink:type="simple">http://apps.who.int/iris/bitstream/10665/254659/1/9789241512046-eng.pdf</uri> Accessed July 18, 2018</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>LL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tucci</surname><given-names>DL</given-names></name></person-group>
<article-title>Hearing loss in adults</article-title>. <source/>N Engl J Med. <year>2017</year>;<volume>377</volume>:<fpage>2465</fpage>–<lpage>2473</lpage><pub-id pub-id-type="pmid">29262274</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucci</surname><given-names>DL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilson</surname><given-names>BS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Donoghue</surname><given-names>GM</given-names></name></person-group>
<article-title>The growing-and now alarming-burden of hearing loss worldwide</article-title>. <source/>Otol Neurotol. <year>2017</year>;<volume>38</volume>:<fpage>1387</fpage>–<lpage>1388</lpage><pub-id pub-id-type="pmid">29065094</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>BS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tucci</surname><given-names>DL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Merson</surname><given-names>MH</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Global hearing health care: new findings and perspectives</article-title>. <source/>Lancet. <year>2017</year>;<volume>390</volume>:<fpage>2503</fpage>–<lpage>2515</lpage><pub-id pub-id-type="pmid">28705460</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowson</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hertzano</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tucci</surname><given-names>DL</given-names></name></person-group>
<article-title>Emerging therapies for sensorineural hearing loss</article-title>. <source/>Otol Neurotol. <year>2017</year>;<volume>38</volume>:<fpage>792</fpage>–<lpage>803</lpage><pub-id pub-id-type="pmid">28383465</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralli</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rolesi</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Anzivino</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Acquired sensorineural hearing loss in children: current research and therapeutic perspectives</article-title>. <source/>Acta Otorhinolaryngol Ital. <year>2017</year>;<volume>37</volume>:<fpage>500</fpage>–<lpage>508</lpage><pub-id pub-id-type="pmid">29327735</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>CA</given-names></name></person-group>
<article-title>Tinnitus</article-title>. <source/>N Engl J Med. <year>2018</year>;<volume>378</volume>:<fpage>1224</fpage>–<lpage>1231</lpage><pub-id pub-id-type="pmid">29601255</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>CS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Emmett</surname><given-names>SD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Robler</surname><given-names>SK</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Global hearing loss prevention</article-title>. <source/>Otolaryngol Clin N Am. <year>2018</year>;<volume>51</volume>:<fpage>575</fpage>–<lpage>592</lpage></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sha</surname><given-names>SH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schacht</surname><given-names>J</given-names></name></person-group>
<article-title>Emerging therapeutic interventions against noise-induced hearing loss</article-title>. <source/>Expert Opin Invest Drugs. <year>2017</year>;<volume>26</volume>:<fpage>85</fpage>–<lpage>96</lpage></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D-H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jing Xie</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The histone deacetylase inhibitor sodium butyrate protects against noise-induced hearing loss in Guinea pigs</article-title>. <source/>Neurosci Lett. <year>2017</year>;<volume>660</volume>:<fpage>140</fpage>–<lpage>146</lpage><pub-id pub-id-type="pmid">28928030</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frenzilli</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ryskalin</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferrucci</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Loud noise exposure produces DNA, neurotransmitter and morphological damage within specific brain areas</article-title>. <source/>Front Neuroanat. <year>2017</year>;<volume>11</volume>:<fpage>49</fpage><pub-id pub-id-type="pmid">28694773</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimantho</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hanantya</surname><given-names>MW</given-names></name></person-group>
<article-title>Enhancing the management of the noise level using six sigma method: a case study on the machining industry</article-title>. <source/>IOP Conf Ser Mater Sci Eng. <year>2017</year>;<volume>277</volume>:<fpage>012055</fpage></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>CMKL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ma</surname><given-names>AK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cushing</surname><given-names>SL</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Noise exposure while commuting in Toronto—a study of personal and public transportation in Toronto</article-title>. <source/>J Otolaryngol Head Neck Surg. <year>2017</year>;<volume>46</volume>:<fpage>62</fpage><pub-id pub-id-type="pmid">29166946</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Münzel</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sørensen</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The adverse effects of environmental noise exposure on oxidative stress and cardiovascular risk</article-title>. <source/>Antioxid Redox Signal. <year>2018</year>;<volume>28</volume>:<fpage>873</fpage>–<lpage>908</lpage><pub-id pub-id-type="pmid">29350061</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Hattab</surname><given-names>AW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zarante</surname><given-names>AM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Almannai</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Therapies for mitochondrial diseases and current clinical trials</article-title>. <source/>Mol Genet Metab. <year>2017</year>;<volume>122</volume>:<fpage>1</fpage>–<lpage>9</lpage></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teplova</surname><given-names>VV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Deryabina</surname><given-names>YI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Isakova</surname><given-names>EP</given-names></name></person-group>
<article-title>Mitochondrial cytopathies: their causes and correction pathways</article-title>. <source/>Biochem Mosc Suppl Ser A Membr Cell Biol. <year>2017</year>;<volume>11</volume>:<fpage>87</fpage>–<lpage>102</lpage></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamogashira</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yamasoba</surname><given-names>T</given-names></name></person-group>
<article-title>Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss</article-title>. <source/>BioMed Res Int. <year>2015</year>;<volume>2015</volume>:<fpage>617207</fpage><pub-id pub-id-type="pmid">25874222</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Histone deacetylase inhibitor sodium butyrate attenuates gentamicin-induced hearing loss <italic>in vivo</italic></article-title>. <source/>Am J Otolaryngol. <year>2015</year>;<volume>36</volume>:<fpage>242</fpage>–<lpage>248</lpage><pub-id pub-id-type="pmid">25554003</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Histone deacetylases in hearing loss: current perspectives for therapy</article-title>. <source/>J Otol. <year>2017</year>;<volume>12</volume>:<fpage>47.e54</fpage><pub-id pub-id-type="pmid">29937837</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Karasawa</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Steyger</surname><given-names>PS</given-names></name></person-group>
<article-title>Aminoglycoside-induced cochleotoxicity: a review</article-title>. <source/>Front Cell Neurosci. <year>2017</year>;<volume>11</volume>:<fpage>308</fpage><pub-id pub-id-type="pmid">29062271</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Owens</surname><given-names>KN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Herr</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Phenotypic optimization of urea−thiophene carboxamides to yield potent, well tolerated, and orally active protective agents against aminoglycoside-induced hearing loss</article-title>. <source/>J Med Chem. <year>2018</year>;<volume>61</volume>:<fpage>84</fpage>–<lpage>97</lpage><pub-id pub-id-type="pmid">28992413</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name>, <etal>et al.</etal></person-group>
<article-title>A mitochondrial targeting tetrapeptide Bendavia protects lateral line hair cells from gentamicin exposure</article-title>. <source/>J Appl Toxicol. <year>2018</year>;<volume>38</volume>:<fpage>376</fpage>–<lpage>384</lpage><pub-id pub-id-type="pmid">29105116</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noack</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pak</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jalota</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>An antioxidant screen identifies candidates for protection of cochlear hair cells from gentamicin toxicity</article-title>. <source/>Front Cell Neurosci. <year>2017</year>;<volume>11</volume>:<fpage>242</fpage><pub-id pub-id-type="pmid">28867994</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheth</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mukherjea</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rybak</surname><given-names>LP</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Mechanisms of cisplatin-induced ototoxicity and otoprotection</article-title>. <source/>Front Cell Neurosci. <year>2017</year>;<volume>11</volume>:<fpage>338</fpage><pub-id pub-id-type="pmid">29163050</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>MJ</given-names></name></person-group>
<article-title>Off-target effects of drugs that disrupt human mitochondrial DNA maintenance</article-title>. <source/>Front Mol Biosci. <year>2017</year>;<volume>4</volume>:<fpage>74</fpage><pub-id pub-id-type="pmid">29214156</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazlitt</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Min</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zuo</surname><given-names>J</given-names></name></person-group>
<article-title>Progress in the development of preventative drugs for cisplatin-induced hearing loss</article-title>. <source/>J Med Chem
<year>2018</year> [Epub ahead of print]. DOI:<pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b01653</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>L-Q</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>D-P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Guo</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial</article-title>. <source/>Lancet Oncol. <year>2018</year>;<volume>19</volume>:<fpage>461</fpage>–<lpage>473</lpage><pub-id pub-id-type="pmid">29501366</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teitz</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fang</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goktug</surname><given-names>AN</given-names></name>, <etal>et al.</etal></person-group>
<article-title>CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss</article-title>. <source/>J Exp Med. <year>2018</year>;<volume>215</volume>:<fpage>1187</fpage>–<lpage>1203</lpage><pub-id pub-id-type="pmid">29514916</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Sullivan</surname><given-names>ME</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>AG</given-names></name></person-group>
<article-title>Mind your ears: a new antidote to aminoglycoside toxicity?</article-title>
<source/>J Med Chem. <year>2018</year>;<volume>61</volume>:<fpage>81</fpage>–<lpage>83</lpage><pub-id pub-id-type="pmid">29256598</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>R</given-names></name></person-group>
<article-title>Long-term noise exposures: a brief review</article-title>. <source/>Hear Res. <year>2017</year>;<volume>349</volume>:<fpage>31</fpage>–<lpage>33</lpage><pub-id pub-id-type="pmid">27780746</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilder</surname><given-names>AGM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blackshaw</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lenarz</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Biological therapies of the inner ear: what otologists need to consider</article-title>. <source/>Otol Neurotol. <year>2018</year>;<volume>39</volume>:<fpage>135</fpage>–<lpage>137</lpage><pub-id pub-id-type="pmid">29315175</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinh</surname><given-names>CT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bas</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Molecular regulation of auditory hair cell death and approaches to protect sensory receptor cells and/or stimulate repair following acoustic trauma</article-title>. <source/>Front Cell Neurosci. <year>2015</year>;<volume>9:</volume><fpage>96</fpage><pub-id pub-id-type="pmid">25873860</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>WJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yin</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clonal expansion of Lgr5-positive cells from mammalian cochlea and high-purity generation of sensory hair cells</article-title>. <source/>Cell Rep. <year>2017</year>;<volume>18</volume>:<fpage>1917</fpage>–<lpage>1929</lpage><pub-id pub-id-type="pmid">28228258</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>BM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Curhan</surname><given-names>SG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Duration of analgesic use and risk of hearing loss in women</article-title>. <source/>Am J Epidemiol. <year>2017</year>;<volume>185</volume>:<fpage>40</fpage>–<lpage>47</lpage><pub-id pub-id-type="pmid">27974293</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>VYW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Black</surname><given-names>SE</given-names></name></person-group>
<article-title>Linking deafness and dementia: challenges and opportunities</article-title>. <source/>Otol Neurotol. <year>2017</year>;<volume>38</volume>:<fpage>e237</fpage>–<lpage>e239</lpage><pub-id pub-id-type="pmid">28806332</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livingston</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sommerlad</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Orgeta</surname><given-names>V</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Dementia prevention, intervention, and care</article-title>. <source/>Lancet. <year>2017</year>;<volume>390</volume>:<fpage>2673</fpage>–<lpage>2734</lpage><pub-id pub-id-type="pmid">28735855</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>EB</given-names></name></person-group>
<article-title>Prevention of late-life dementia: no magic bullet</article-title>. <source/>Ann Intern Med. <year>2018</year>;<volume>168</volume>:<fpage>77</fpage>–<lpage>79</lpage><pub-id pub-id-type="pmid">29255884</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loughrey</surname><given-names>DG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kelly</surname><given-names>ME</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kelley</surname><given-names>GA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia. A systematic review and meta-analysis</article-title>. <source/>JAMA Otolaryngol Head Neck Surg. <year>2018</year>;<volume>144</volume>:<fpage>115</fpage>–<lpage>126</lpage><pub-id pub-id-type="pmid">29222544</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>MH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moos</surname><given-names>WH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faller</surname><given-names>DV</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epigenetic treatment of neurodegenerative disorders: Alzheimer and Parkinson diseases</article-title>. <source/>Drug Dev Res. <year>2016</year>;<volume>77</volume>:<fpage>109</fpage>–<lpage>123</lpage><pub-id pub-id-type="pmid">26899010</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moos</surname><given-names>WH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faller</surname><given-names>DV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Harpp</surname><given-names>DN</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Microbiota and neurological disorders: a gut feeling</article-title>. <source/>BioRes Open Access. <year>2016</year>;<volume>5</volume>:<fpage>137</fpage>–<lpage>145</lpage><pub-id pub-id-type="pmid">27274912</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Declerck</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vanden Berghe</surname><given-names>W</given-names></name></person-group>
<article-title>Back to the future: epigenetic clock plasticity towards healthy aging</article-title>. <source/>Mech Ageing Dev. <year>2018</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1016/j.mad.2018.01.002</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moos</surname><given-names>WH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pinkert</surname><given-names>CA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Irwin</surname><given-names>MH</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epigenetic treatment of persistent viral infections</article-title>. <source/>Drug Dev Res. <year>2017</year>;<volume>78</volume>:<fpage>24</fpage>–<lpage>36</lpage><pub-id pub-id-type="pmid">27761936</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rambold</surname><given-names>AS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pearce</surname><given-names>EL</given-names></name></person-group>
<article-title>Mitochondrial dynamics at the interface of immune cell metabolism and function</article-title>. <source/>Trends Immunol. <year>2018</year>;<volume>39</volume>:<fpage>6</fpage>–<lpage>18</lpage><pub-id pub-id-type="pmid">28923365</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorrentino</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Menzies</surname><given-names>KJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group>
<article-title>Repairing mitochondrial dysfunction in disease</article-title>. <source/>Annu Rev Pharmacol Toxicol. <year>2018</year>;<volume>58</volume>:<fpage>353</fpage>–<lpage>389</lpage><pub-id pub-id-type="pmid">28961065</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garatachea</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pareja-Galeano</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sanchis-Gomar</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Exercise attenuates the major hallmarks of aging</article-title>. <source/>Rejuvenation Res. <year>2015</year>;<volume>18</volume>:<fpage>57</fpage>–<lpage>89</lpage><pub-id pub-id-type="pmid">25431878</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moos</surname><given-names>WH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maneta</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pinkert</surname><given-names>CA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Epigenetic treatment of neuropsychiatric disorders: autism and schizophrenia</article-title>. <source/>Drug Dev Res. <year>2016</year>;<volume>77</volume>:<fpage>53</fpage>–<lpage>72</lpage><pub-id pub-id-type="pmid">26899191</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eckert</surname><given-names>A</given-names></name></person-group>
<article-title>Brain aging and neurodegeneration: from a mitochondrial point of view</article-title>. <source/>J Neurochem. <year>2017</year>;<volume>143</volume>:<fpage>418</fpage>–<lpage>431</lpage><pub-id pub-id-type="pmid">28397282</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Magalhães</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Passos</surname><given-names>JF</given-names></name></person-group>
<article-title>Stress, cell senescence and organismal ageing</article-title>. <source/>Mech Ageing Dev. <year>2018</year>;<volume>170</volume>:<fpage>2</fpage>–<lpage>9</lpage><pub-id pub-id-type="pmid">28688962</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W</given-names></name>, <etal>et al.</etal></person-group>
<article-title>MicroRNAs and presbycusis</article-title>. <source/>Aging Dis. <year>2018</year>;<volume>9</volume>:<fpage>133</fpage>–<lpage>142</lpage><pub-id pub-id-type="pmid">29392088</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kucheryavenko</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wordsworth</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The senescent bystander effect is caused by ROS-activated NF-κB signaling</article-title>. <source/>Mech Ageing Dev. <year>2018</year>;<volume>170</volume>:<fpage>30</fpage>–<lpage>36</lpage><pub-id pub-id-type="pmid">28837845</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theurey</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pizzo</surname><given-names>P</given-names></name></person-group>
<article-title>The aging mitochondria</article-title>. <source/>Genes. <year>2018</year>;<volume>9</volume>:<fpage>22</fpage></mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>WJT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Song</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Graham</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Novel role of the mitochondrial protein fus1 in protection from premature hearing loss via regulation of oxidative stress and nutrient and energy sensing pathways in the inner ear</article-title>. <source/>Antioxid Redox Signal. <year>2017</year>;<volume>27</volume>:<fpage>489</fpage>–<lpage>509</lpage><pub-id pub-id-type="pmid">28135838</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>García-Cazorla</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wolf</surname><given-names>NI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mochel</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neurological disease</article-title>. In: <source/>Inherited Metabolic Diseases: A Clinical Approach Second Edition: Berlin, Germany
<person-group person-group-type="editor"><name><surname>Georg</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Hoffmann</surname><given-names>GF</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Zschocke</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Nyhan</surname><given-names>WL</given-names></name></person-group>, (eds.). <publisher-name>Springer-Verlag GmbH</publisher-name>: <publisher-loc>Berlin Heidelberg</publisher-loc>; pp. <fpage>251</fpage>–<lpage>292</lpage>; <year>2018</year>; <comment>Chapter 27.</comment></mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name></person-group>
<article-title>Recent perspectives of pediatric mitochondrial diseases (Review)</article-title>. <source/>Exp Ther Med. <year>2018</year>;<volume>15</volume>:<fpage>13</fpage>–<lpage>18</lpage><pub-id pub-id-type="pmid">29375674</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grier</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hirano</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Karaa</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Diagnostic odyssey of patients with mitochondrial disease</article-title>. <source/>Neurol Genet. <year>2018</year>;<volume>4</volume>:<fpage>e230</fpage><pub-id pub-id-type="pmid">29600276</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapnick</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>SE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McGuire</surname><given-names>PJ</given-names></name></person-group>
<article-title>The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism</article-title>. <source/>Metabolism. <year>2018;</year><volume>81</volume>:<fpage>97</fpage>–<lpage>112</lpage><pub-id pub-id-type="pmid">29162500</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuszak</surname><given-names>AJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Espey</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Falk</surname><given-names>MJ</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Nutritional interventions for mitochondrial OXPHOS deficiencies: mechanisms and model systems</article-title>. <source/>Annu Rev Pathol Mech Dis. <year>2018</year>;<volume>13</volume>:<fpage>163</fpage>–<lpage>191</lpage></mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suomalainen</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Battersby</surname><given-names>BJ</given-names></name></person-group>
<article-title>Mitochondrial diseases: the contribution of organelle stress responses to pathology</article-title>. <source/>Nat Rev Mol Cell Biol. <year>2018</year>;<volume>19</volume>:<fpage>77</fpage>–<lpage>92</lpage><pub-id pub-id-type="pmid">28792006</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosebush</surname><given-names>PI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Anglin</surname><given-names>RE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Mental illness in patients with inherited mitochondrial disorders</article-title>. <source/>Schizophr Res. <year>2017</year>;<volume>187</volume>:<fpage>33</fpage>–<lpage>37</lpage><pub-id pub-id-type="pmid">28545943</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cataldo</surname><given-names>LR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Olmos</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Smalley</surname><given-names>SV</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Mitochondrial DNA heteroplasmy of the m.3243A&gt;G mutation in maternally inherited diabetes and deafness. [In Spanish]</article-title>. <source/>Rev Med Chil. <year>2013</year>;<volume>141</volume>:<fpage>305</fpage>–<lpage>312</lpage><pub-id pub-id-type="pmid">23900320</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>RL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liang</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sue</surname><given-names>CM</given-names></name></person-group>
<article-title>Mitochondrial diseases</article-title>. In: <source/>Handbook of Clinical Neurology, vol. 147 (3rd series). Neurogenetics, Part I. <person-group person-group-type="editor"><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Paulson</surname><given-names>HL</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Klein</surname><given-names>C</given-names></name></person-group>, (eds.). <publisher-name>Elsevier</publisher-name>: <publisher-loc>Amsterdam, Netherlands</publisher-loc>; pp. <fpage>125</fpage>–<lpage>141</lpage>; <year>2018</year>.</mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiMauro</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schon</surname><given-names>EA</given-names></name></person-group>
<article-title>Mitochondrial respiratory-chain diseases</article-title>. <source/>N Engl J Med. <year>2003</year>;<volume>348</volume>:<fpage>2656</fpage>–<lpage>2668</lpage><pub-id pub-id-type="pmid">12826641</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leng</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fan</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The role of mitochondrial DNA mutations in hearing loss</article-title>. <source/>Biochem Genet. <year>2013</year>;<volume>51</volume>:<fpage>588</fpage>–<lpage>602</lpage><pub-id pub-id-type="pmid">23605717</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finsterer</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Frank</surname><given-names>M</given-names></name></person-group>
<article-title>Maternally inherited diabetes and deafness is phenotypically and genotypically heterogeneous</article-title>. <source/>J NeuroOphthalmol. <year>2016</year>;<volume>36</volume>:<fpage>346</fpage>–<lpage>347</lpage><pub-id pub-id-type="pmid">27286552</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gale</surname><given-names>M</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Mitochondria and antiviral immunity</article-title>. In: <source/>Mitochondria and Cell Death.
<person-group person-group-type="author"><name><surname>Hockenbery</surname><given-names>DM</given-names></name></person-group><comment>, (ed.)</comment>
<publisher-name>Springer</publisher-name>: <publisher-loc>New York, NY</publisher-loc>; pp. <fpage>187</fpage>–<lpage>212</lpage>; <year>2016</year>; <comment>Chapter 10.</comment></mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>MM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weinberg</surname><given-names>SE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group>
<article-title>Mitochondrial control of immunity: beyond ATP</article-title>. <source/>Nat Rev Immunol. <year>2017</year>;<volume>17</volume>:<fpage>608</fpage>–<lpage>620</lpage><pub-id pub-id-type="pmid">28669986</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachmann</surname><given-names>HJ</given-names></name></person-group>
<article-title>Periodic fever syndromes</article-title>. <source/>Best Pract Res Clin Rheumatol.
<year>2018</year>;<volume>31</volume>:<fpage>596</fpage>–<lpage>609</lpage></mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J-L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mukda</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>S-D</given-names></name></person-group>
<article-title>Diverse roles of mitochondria in ischemic stroke</article-title>. <source/>Redox Biol. <year>2018</year>;<volume>16</volume>:<fpage>263</fpage>–<lpage>275</lpage><pub-id pub-id-type="pmid">29549824</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>BE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durstenfeld</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roehm</surname><given-names>PC</given-names></name></person-group>
<article-title>Viral causes of hearing loss: a review for hearing health professionals</article-title>. <source/>Trends Hear. <year>2014</year>;<volume>22</volume>:<fpage>1</fpage>–<lpage>17</lpage></mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>NE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ronca</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tamura</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Animal model of sensorineural hearing loss associated with Lassa virus infection</article-title>. <source/>J Virol. <year>2016</year>;<volume>90</volume>:<fpage>2920</fpage>–<lpage>2927</lpage></mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byun</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chung</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Clinical value of 4-hour delayed gadolinium-enhanced 3D FLAIR MR images in acute vestibular neuritis</article-title>. <source/>Laryngoscope. <year>2018</year> [Epub ahead of print]; DOI:<pub-id pub-id-type="doi">10.1002/lary.27084</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhutta</surname><given-names>MF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thornton</surname><given-names>RB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kirkham</surname><given-names>L-AS</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Understanding the aetiology and resolution of chronic otitis media from animal and human studies</article-title>. <source/>Dis Model Mech. <year>2017</year>;<volume>10</volume>:<fpage>1289</fpage>–<lpage>1300</lpage><pub-id pub-id-type="pmid">29125825</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Capece</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Begalli</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>NF-κB in the crosshairs: rethinking an old riddle</article-title>. <source/>Int J Biochem Cell Biol. <year>2018</year>;<volume>95</volume>:<fpage>108</fpage>–<lpage>112</lpage><pub-id pub-id-type="pmid">29277662</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miguel</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cui</surname><given-names>JY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Daimiel</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The role of microRNAs in environmental risk factors, noise-induced hearing loss, and mental stress</article-title>. <source/>Antioxid Redox Signal. <year>2018</year>;<volume>28</volume>:<fpage>773</fpage>–<lpage>796</lpage><pub-id pub-id-type="pmid">28562070</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salinaro</surname><given-names>AT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pennisi</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Di Paola</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer's disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms</article-title>. <source/>Immun Ageing. <year>2018</year>;<volume>15</volume>:8</mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>ACY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ryan</surname><given-names>AF</given-names></name></person-group>
<article-title>Mechanisms of sensorineural cell damage, death and survival in the cochlea</article-title>. <source/>Front Aging Neurosci. <year>2015</year>;<volume>7</volume>:<fpage>58</fpage><pub-id pub-id-type="pmid">25954196</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghezzi</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Floridi</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boraschi</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Oxidative stress and inflammation induced by environmental and psychological stressors: a biomarker perspective</article-title>. <source/>Antioxid Redox Signal. <year>2018</year>;<volume>28</volume>:<fpage>852</fpage>–<lpage>872</lpage><pub-id pub-id-type="pmid">28494612</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>W</given-names></name></person-group>
<article-title>Toward a true cure for hearing impairment</article-title>. <source/>Science. <year>2018</year>;<volume>359</volume>:1113</mixed-citation>
</ref>
<ref id="B87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atilgan</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Town</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wood</surname><given-names>KC</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Integration of visual information in auditory cortex promotes auditory scene analysis through multisensory binding</article-title>. <source/>Neuron. <year>2018</year>;<volume>97</volume>:<fpage>640</fpage>–<lpage>655</lpage><pub-id pub-id-type="pmid">29395914</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flanagan</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zorilă</surname><given-names>T-C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stylianou</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Speech processing to improve the perception of speech in background noise for children with auditory processing disorder and typically developing peers</article-title>. <source/>Trends Hear. <year>2018</year>;<volume>22</volume>:<fpage>1</fpage></mixed-citation>
</ref>
<ref id="B89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ren</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Comprehensive molecular screening in Chinese Usher syndrome patients</article-title>. <source/>Invest Ophthalmol Vis Sci. <year>2018</year>;<volume>59</volume>:<fpage>1229</fpage>–<lpage>1237</lpage><pub-id pub-id-type="pmid">29625443</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Masuda</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaga</surname><given-names>K</given-names></name></person-group>
<article-title>Vestibular function and gross motor development in 195 children with congenital hearing loss—assessment of inner ear malformations</article-title>. <source/>Otol Neurotol. <year>2018</year>;<volume>39</volume>:<fpage>196</fpage>–<lpage>205</lpage><pub-id pub-id-type="pmid">29315185</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>RL 2nd</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hampton</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Green-McKenzie</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Neurological manifestations among US government personnel reporting directional audible and sensory phenomena in Havana, Cuba</article-title>. <source/>JAMA
<year>2018;</year><volume>319</volume>:<fpage>1125</fpage>–<lpage>1133</lpage><pub-id pub-id-type="pmid">29450484</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Omar</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gopal</surname><given-names>SR</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Modeling and preventing progressive hearing loss in Usher syndrome III.</article-title>
<source/>Nat.
<source/>Sci Rep. <year>2017</year>;<volume>7</volume>:<fpage>13480</fpage></mixed-citation>
</ref>
<ref id="B93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>WW</given-names></name></person-group>
<article-title>A CRISPR way to restore hearing</article-title>. <source/>N Engl J Med. <year>2018</year>;<volume>378</volume>:<fpage>1255</fpage>–<lpage>1256</lpage><pub-id pub-id-type="pmid">29601257</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tao</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lamas</surname><given-names>V</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents</article-title>. <source/>Nature. <year>2018</year>;<volume>553</volume>:<fpage>217</fpage>–<lpage>221</lpage><pub-id pub-id-type="pmid">29258297</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamakura</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Malley</surname><given-names>JT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nadol</surname><given-names>JB</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Preservation of cells of the organ of Corti and innervating dendritic processes following cochlear implantation in the human: an immunohistochemical study</article-title>. <source/>Otol Neurotol. <year>2018</year>;<volume>39</volume>:<fpage>284</fpage>–<lpage>293</lpage><pub-id pub-id-type="pmid">29342037</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakat</surname><given-names>MS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kilic</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bercin</surname><given-names>S</given-names></name></person-group>
<article-title>Pharmacological agents used for treatment and prevention in noise-induced hearing loss</article-title>. <source/>Eur Arch Otorhinolaryngol. <year>2016</year>;<volume>273</volume>:<fpage>4089</fpage>–<lpage>4101</lpage><pub-id pub-id-type="pmid">26882913</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petremann</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ba</surname><given-names>CTV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Broussy</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Oral administration of clinical stage drug candidate SENS-401 effectively reduces cisplatin-induced hearing loss in rats</article-title>. <source/>Otol Neurotol. <year>2017</year>;<volume>38</volume>:<fpage>1355</fpage>–<lpage>1361</lpage><pub-id pub-id-type="pmid">28796092</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirain</surname><given-names>CO</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ng</surname><given-names>MRAV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Milne-Davies</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Evaluation of mitoquinone for protecting against amikacin-induced ototoxicity in guinea pigs</article-title>. <source/>Otol Neurotol. <year>2018</year>;<volume>39</volume>:<fpage>111</fpage>–<lpage>118</lpage><pub-id pub-id-type="pmid">29194212</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golbidi</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Laher</surname><given-names>I</given-names></name></person-group>
<article-title>Oxidative stress: a unifying mechanism for cell damage induced by noise, (water-pipe) smoking, and emotional stress—therapeutic strategies targeting redox imbalance</article-title>. <source/>Antioxid Redox Signal. <year>2018</year>;<volume>28</volume>:<fpage>741</fpage>–<lpage>759</lpage><pub-id pub-id-type="pmid">29212347</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilmore</surname><given-names>TD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Herscovitch</surname><given-names>M</given-names></name></person-group>
<article-title>Inhibitors of NF-κB signaling: 785 and counting</article-title>. <source/>Nat Oncogene. <year>2006</year>;<volume>25</volume>:<fpage>6887</fpage>–<lpage>6899</lpage></mixed-citation>
</ref>
<ref id="B101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steliou</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boosalis</surname><given-names>MS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perrine</surname><given-names>SP</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Butyrate histone deacetylase inhibitors</article-title>. <source/>BioRes Open Access. <year>2012</year>;<volume>1</volume>:<fpage>192</fpage>–<lpage>198</lpage><pub-id pub-id-type="pmid">23514803</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galland</surname><given-names>L</given-names></name></person-group>
<article-title>The gut microbiome and the brain</article-title>. <source/>J Med Food. <year>2014</year>;<volume>17</volume>:<fpage>1261</fpage>–<lpage>1272</lpage><pub-id pub-id-type="pmid">25402818</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yedery</surname><given-names>RD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jerse</surname><given-names>AE</given-names></name></person-group>
<article-title>Augmentation of cationic antimicrobial peptide production with histone deacetylase inhibitors as a novel epigenetic therapy for bacterial infections</article-title>. <source/>Antibiotics. <year>2015</year>;<volume>4</volume>:<fpage>44</fpage>–<lpage>61</lpage><pub-id pub-id-type="pmid">27025614</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>LS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Davies</surname><given-names>SS</given-names></name></person-group>
<article-title>Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions</article-title>. <source/>Genome Med. <year>2016</year>;<volume>8</volume>:<fpage>46</fpage><pub-id pub-id-type="pmid">27102537</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>He</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Butyrate: a double-edged sword for health?</article-title>
<source/>Adv Nutr. <year>2018</year>;<volume>9</volume>:<fpage>21</fpage>–<lpage>29</lpage><pub-id pub-id-type="pmid">29438462</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kampfrath</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function</article-title>. <source/>Inflamm Res. <year>2011</year>;<volume>60</volume>:<fpage>219</fpage>–<lpage>225</lpage><pub-id pub-id-type="pmid">20927568</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochette</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghibu</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Muresan</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes</article-title>. <source/>Can J Physiol Pharmacol. <year>2015</year>;<volume>93</volume>:<fpage>1021</fpage>–<lpage>1027</lpage><pub-id pub-id-type="pmid">26406389</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>MY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gwon</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>HS</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The effect of systemic lipoic acid on hearing preservation after cochlear implantation via the round window approach: a guinea pig model</article-title>. <source/>Eur J Pharmacol. <year>2017</year>;<volume>799</volume>:<fpage>67</fpage>–<lpage>72</lpage><pub-id pub-id-type="pmid">28159538</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tibullo</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Volti</surname><given-names>GV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Giallongo</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential</article-title>. <source/>Inflamm Res. <year>2017</year>;<volume>66</volume>:<fpage>947</fpage>–<lpage>959</lpage><pub-id pub-id-type="pmid">28676917</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bu</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Lipoic acid inhibited desflurane-induced hippocampal neuronal apoptosis through Caspase3 and NF-KappaB dependent pathway</article-title>. <source/>Tissue Cell. <year>2018</year>;<volume>50</volume>:<fpage>37</fpage>–<lpage>42</lpage><pub-id pub-id-type="pmid">29429516</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dhar</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Raj</surname><given-names>D</given-names></name></person-group>, et al. <article-title>Alpha lipoic acid (ALA) modulates expression of apoptosis associated proteins in hippocampus of rats exposed during postnatal period to sodium arsenite (NaAsO<sub>2</sub>)</article-title>. <source/>Toxicol Rep. <year>2015</year>;<volume>2</volume>:<fpage>78</fpage>–<lpage>87</lpage><pub-id pub-id-type="pmid">28962340</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Rasheed</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faddah</surname><given-names>LM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hasan</surname><given-names>IH</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Amelioration of panadol-induced nephrotoxicity via down-regulation of Bax/Bcl2 ratio with some antioxidants</article-title>. <source/>Pharmacol Rep. <year>2017</year>;<volume>69</volume>:<fpage>1088</fpage>–<lpage>1093</lpage><pub-id pub-id-type="pmid">28988613</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanadgol</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Golab</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Askari</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation</article-title>. <source/>Metab Brain Dis. <year>2018</year>;<volume>33</volume>:<fpage>27</fpage>–<lpage>37</lpage><pub-id pub-id-type="pmid">29022246</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosini</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Simoni</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bartolini</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease</article-title>. <source/>Eur J Med Chem. <year>2011</year>;<volume>46</volume>:<fpage>5435</fpage>–<lpage>5442</lpage><pub-id pub-id-type="pmid">21924801</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scumpia</surname><given-names>PO</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kelly-Scumpia</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stevens</surname><given-names>BR</given-names></name></person-group>
<article-title>Alpha-lipoic acid effects on brain glial functions accompanying double-stranded RNA antiviral and inflammatory signaling</article-title>. <source/>Neurochem Int. <year>2016</year>;<volume>64</volume>:<fpage>55</fpage>–<lpage>63</lpage></mixed-citation>
</ref>
<ref id="B116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirani</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Okuda</surname><given-names>DT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stüve</surname><given-names>O</given-names></name></person-group>
<article-title>Therapeutic advances and future prospects in progressive forms of multiple sclerosis</article-title>. <source/>Neurotherapeutics. <year>2016</year>;<volume>13</volume>:<fpage>58</fpage>–<lpage>69</lpage><pub-id pub-id-type="pmid">26729332</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Luo</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name>, <etal>et al.</etal></person-group>
<article-title>α-Lipoic acid alleviates pentetrazol-induced neurological deficits and behavioral dysfunction in rats with seizures <italic>via</italic> an Nrf2 pathway</article-title>. <source/>RSC Adv. <year>2018</year>;<volume>8</volume>:<fpage>4084</fpage>–<lpage>4092</lpage></mixed-citation>
</ref>
<ref id="B118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharif</surname><given-names>NA</given-names></name></person-group>
<article-title><italic>i</italic>Drugs and <italic>i</italic>devices discovery research: preclinical assays, techniques, and animal model studies for ocular hypotensives and neuroprotectants</article-title>. <source/>J Ocul Pharmacol Ther. <year>2018</year>;<volume>34</volume>:<fpage>7</fpage>–<lpage>39</lpage><pub-id pub-id-type="pmid">29323613</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y-H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>D-W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>S-F</given-names></name>, <etal>et al.</etal></person-group>
<article-title>α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice</article-title>. <source/>Redox Biol. <year>2018</year>;<volume>14</volume>:<fpage>535</fpage>–<lpage>548</lpage><pub-id pub-id-type="pmid">29126071</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pu</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Effect of alpha lipoic acid on retinal ganglion cell survival in an optic nerve crush model</article-title>. <source/>Mol Vis. <year>2016</year>;<volume>22</volume>:<fpage>1122</fpage>–<lpage>1136</lpage><pub-id pub-id-type="pmid">27703307</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ogi</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sakashita</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Toll-like receptor ligands induce cytokine and chemokine production in human inner ear endolymphatic sac fibroblasts</article-title>. <source/>Auris Nasus Larynx. <year>2017</year>;<volume>44</volume>:<fpage>398</fpage>–<lpage>403</lpage><pub-id pub-id-type="pmid">27884591</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>DG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kurabi</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ryan</surname><given-names>AF</given-names></name></person-group>
<article-title>Screening antioxidants for the protection of cochlear sensory cells</article-title>. <source/>Neural Regen Res. <year>2018</year>;<volume>13</volume>:<fpage>62</fpage>–<lpage>64</lpage><pub-id pub-id-type="pmid">29451206</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronan</surname><given-names>JE</given-names></name></person-group>
<article-title>Assembly of lipoic acid on its cognate enzymes: an extraordinary and essential biosynthetic pathway</article-title>. <source/>Microbiol Mol Biol Rev. <year>2016</year>;<volume>80</volume>:<fpage>429</fpage>–<lpage>450</lpage><pub-id pub-id-type="pmid">27074917</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steliou</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faller</surname><given-names>DV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pinkert</surname><given-names>CA</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury</article-title>. <source/>Drug Dev Res. <year>2015</year>;<volume>76</volume>:<fpage>167</fpage>–<lpage>175</lpage><pub-id pub-id-type="pmid">26109467</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schüller</surname><given-names>ÁK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Canata</surname><given-names>DAM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hackenhaar</surname><given-names>FS</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Effects of lipoic acid and <italic>n</italic>-3 long-chain polyunsaturated fatty acid on the liver ovariectomized rat model of menopause</article-title>. <source/>Pharmacol Rep. <year>2018</year>;<volume>70</volume>:<fpage>263</fpage>–<lpage>269</lpage><pub-id pub-id-type="pmid">29475009</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group>
<article-title>α-Lipoic acid protects against the cytotoxicity and oxidative stress induced by cadmium in HepG2 cells through regeneration of glutathione by glutathione reductase via Nrf2/ARE signaling pathway</article-title>. <source/>Environ Toxicol Pharmacol. <year>2016</year>;<volume>45</volume>:<fpage>274</fpage>–<lpage>281</lpage><pub-id pub-id-type="pmid">27343752</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scangas</surname><given-names>GA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bleier</surname><given-names>BS</given-names></name></person-group>
<article-title>Anosmia: differential diagnosis, evaluation, and management</article-title>. <source/>Am J Rhinol Allergy. <year>2017</year>;<volume>31</volume>:<fpage>e3</fpage>–<lpage>e7</lpage></mixed-citation>
</ref>
<ref id="B128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuadrado</surname><given-names>A</given-names></name></person-group>
<article-title>NRF2 in neurodegenerative diseases</article-title>. <source/>Curr Opin Toxicol. <year>2016</year>;<volume>1</volume>:<fpage>46</fpage>–<lpage>53</lpage></mixed-citation>
</ref>
<ref id="B129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavanai</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mohammadkhani</surname><given-names>G</given-names></name></person-group>
<article-title>Role of antioxidants in prevention of age-related hearing loss: a review of literature</article-title>. <source/>Eur Arch Otorhinolaryngol. <year>2017</year>;<volume>274</volume>:<fpage>1821</fpage>–<lpage>1834</lpage><pub-id pub-id-type="pmid">27858145</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Someya</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kondo</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Age-related hearing loss in C57BL/6 J mice is mediated by Bak-dependent mitochondrial apoptosis</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2009</year>;<volume>106</volume>:<fpage>19432</fpage>–<lpage>19437</lpage><pub-id pub-id-type="pmid">19901338</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polanski</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cruz</surname><given-names>OL</given-names></name></person-group>
<article-title>Evaluation of antioxidant treatment in presbyacusis: prospective, placebo-controlled, double-blind, randomised trial</article-title>. <source/>J Laryngol Otol. <year>2013</year>;<volume>127</volume>:<fpage>134</fpage>–<lpage>141</lpage><pub-id pub-id-type="pmid">23318104</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name></person-group>
<person-group person-group-type="author"><name><surname>Hill</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sha</surname><given-names>S-H</given-names></name></person-group>
<article-title>Inhibitors of histone deacetylases attenuate noise-induced hearing loss</article-title>. <source/>JARO. <year>2016</year>;<volume>17</volume>:<fpage>289</fpage>–<lpage>302</lpage><pub-id pub-id-type="pmid">27095478</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarezky</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Raquib</surname><given-names>AR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dunaief</surname><given-names>JL</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye</article-title>. <source/>Clin Ophthalmol. <year>2016</year>;<volume>10</volume>:<fpage>1899</fpage>–<lpage>1903</lpage><pub-id pub-id-type="pmid">27729766</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugdahl</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sommer</surname><given-names>IE</given-names></name></person-group>
<article-title>Auditory verbal hallucinations in schizophrenia from a levels of explanation perspective</article-title>. <source/>Schizophr Bull
<year>2018</year>;<volume>44</volume>:<fpage>234</fpage>–<lpage>241</lpage><pub-id pub-id-type="pmid">29069435</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kim</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<article-title>The effect of transcranial direct current stimulation on auditory hallucination in patients with schizophrenia</article-title>. <source/>Schizophr Res. <year>2018</year>;<volume>192</volume>:<fpage>489</fpage>–<lpage>490</lpage><pub-id pub-id-type="pmid">28625741</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonutas</surname><given-names>HM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vekaria</surname><given-names>HJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PG</given-names></name></person-group>
<article-title>Mitochondrial specific therapeutic targets following brain injury</article-title>. <source/>Brain Res. <year>2016</year>;<volume>1640</volume>:<fpage>77</fpage>–<lpage>93</lpage><pub-id pub-id-type="pmid">26872596</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>DK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chang</surname><given-names>KW</given-names></name></person-group>
<article-title>GJB2-associated hearing loss: systematic review of worldwide prevalence, genotype, and auditory phenotype</article-title>. <source/>Laryngoscope. <year>2014</year>;<volume>124</volume>:<fpage>E34</fpage>–<lpage>E53</lpage><pub-id pub-id-type="pmid">23900770</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGeer</surname><given-names>PL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McGeer</surname><given-names>E</given-names></name></person-group>
<article-title>Conquering Alzheimer's disease by self treatment</article-title>. <source/>J Alzheimers Dis. <year>2018;</year><volume>64</volume>:<fpage>S361</fpage>–<lpage>S363</lpage><pub-id pub-id-type="pmid">29562519</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinhouse</surname><given-names>C</given-names></name></person-group>
<article-title>Mitochondrial-epigenetic crosstalk in environmental toxicology</article-title>. <source/>Toxicology. <year>2017</year>;<volume>391</volume>:<fpage>5</fpage>–<lpage>17</lpage><pub-id pub-id-type="pmid">28855114</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>AP</given-names></name></person-group>
<article-title>The key role of epigenetics in human disease prevention and mitigation</article-title>. <source/>N Engl J Med. <year>2018</year>;<volume>378</volume>:<fpage>1323</fpage>–<lpage>1334</lpage><pub-id pub-id-type="pmid">29617578</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kelly</surname><given-names>MC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rehman</surname><given-names>AU</given-names></name>, <etal>et al.</etal></person-group>
<article-title>Defects in the alternative splicing-dependent regulation of REST cause deafness</article-title>. <source/>Cell. <year>2018</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1016/j.cell.2018.06.004</pub-id></mixed-citation>
</ref>
</ref-list>
<ref-list>
<p><bold>Cite this article as:</bold> Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K (2018) A new approach to treating neurodegenerative otologic disorders, <italic>BioResearch Open Access</italic> 7:1, 107–115, DOI: 10.1089/biores.2018.0017.</p>
</ref-list>
<glossary>
<title>Abbreviations Used</title>
<def-list>
<def-item>
<term id="G1">ALA</term>
<def>
<p>α-lipoic acid</p>
</def>
</def-item>
<def-item>
<term id="G2">ARE</term>
<def>
<p>antioxidant response element</p>
</def>
</def-item>
<def-item>
<term id="G3">ARHL</term>
<def>
<p>age-related hearing loss</p>
</def>
</def-item>
<def-item>
<term id="G4">BAX</term>
<def>
<p>Bcl-2-associated X protein</p>
</def>
</def-item>
<def-item>
<term id="G5">Bcl-2</term>
<def>
<p>B cell lymphoma 2</p>
</def>
</def-item>
<def-item>
<term id="G6">GPCR</term>
<def>
<p>G-protein-coupled receptor</p>
</def>
</def-item>
<def-item>
<term id="G7">HDAC</term>
<def>
<p>histone deacetylase</p>
</def>
</def-item>
<def-item>
<term id="G8">HDACi</term>
<def>
<p>histone deacetylase inhibitors</p>
</def>
</def-item>
<def-item>
<term id="G9">LMICs</term>
<def>
<p>low- and middle-income countries</p>
</def>
</def-item>
<def-item>
<term id="G10">mtDNA</term>
<def>
<p>mitochondrial DNA</p>
</def>
</def-item>
<def-item>
<term id="G11">NAC</term>
<def>
<p>N-acetyl-L-cysteine</p>
</def>
</def-item>
<def-item>
<term id="G12">nDNA</term>
<def>
<p>nuclear DNA</p>
</def>
</def-item>
<def-item>
<term id="G13">NF-κB</term>
<def>
<p>nuclear factor kappa B</p>
</def>
</def-item>
<def-item>
<term id="G14">NIHL</term>
<def>
<p>noise-induced hearing loss</p>
</def>
</def-item>
<def-item>
<term id="G15">Nrf2</term>
<def>
<p>nuclear factor erythroid 2-related factor 2</p>
</def>
</def-item>
<def-item>
<term id="G16">NSAID</term>
<def>
<p>nonsteroidal anti-inflammatory drug</p>
</def>
</def-item>
<def-item>
<term id="G17">RP</term>
<def>
<p>retinitis pigmentosa</p>
</def>
</def-item>
<def-item>
<term id="G18">SNHL</term>
<def>
<p>sensorineural hearing loss</p>
</def>
</def-item>
<def-item>
<term id="G19">TBI</term>
<def>
<p>traumatic brain injury</p>
</def>
</def-item>
<def-item>
<term id="G20">WHO</term>
<def>
<p>World Health Organization</p>
</def>
</def-item>
<def-item>
<term id="G21">YLDs</term>
<def>
<p>years lived with disability</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>